+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5442029
  • Report
  • September 2021
  • Region: Global
  • 145 Pages
  • IMARC Group

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Qiagen N.V.
The global oncology molecular diagnostics market is expected to grow at a CAGR of 12.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation


The analyst provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on region, cancer type, product, technology and end-user.

Breakup by Cancer Type

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Others

Breakup by Product

  • Instruments
  • Reagents
  • Others

Breakup by Technology

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Chips and Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • DNA and NGS Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others

Breakup by End-user

  • Hospitals and Clinics
  • Reference Laboratories
  • Others

Breakup by Region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Abbott Laboratories, Bayer AG, BD (Becton, Dickinson and Company), Cepheid Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Qiagen N.V.
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Cancer Type
6.1 Breast Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Prostate Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Colorectal Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cervical Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Liver Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Lung Cancer
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Blood Cancer
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast

7 Market Breakup by Product
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reagents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Technology
8.1 Polymerase Chain Reaction (PCR)
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 In Situ Hybridization
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chips and Microarrays
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Mass Spectrometry
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 DNA and NGS Sequencing
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Transcription Mediated Amplification (TMA)
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Others
8.8.1 Market Trends
8.8.2 Market Forecast

9 Market Breakup by End-user
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Abbott Laboratories
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BD (Becton, Dickinson and Company)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Cepheid Inc (Danaher Corporation)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Hologic, Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Qiagen N.V.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Siemens Healthcare
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sysmex Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis


List of Figures
Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2020
Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2020
Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2020
Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2020
Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2020
Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2020-2005
Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables
Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2021-2026
Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Oncology Molecular Diagnostics Market Structure
Table 8: Global: Oncology Molecular Diagnostics Market: Key Players
Note: Product cover images may vary from those shown
  • Agilent Technologies Inc.
  • Abbott Laboratories
  • Bayer AG
  • BD (Becton, Dickinson and Company)
  • Cepheid Inc. (Danaher Corporation)
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Qiagen N.V.
  • Siemens Healthcare and Sysmex Corporation.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll